Episode 7: Andrea James on IMDX's Bright Future, Democratizing Molecular Diagnostics, and Investing Thoughts

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/a0/a8/d2/a0a8d294-8300-c919-d37e-5147c9eec39b/mza_7086622905097055136.jpg/600x600bb.jpg

Shooting the Bull With Drowsy and Bear

Drowsy Investor

9 episodes

1 week ago

Two old guys talking stocks, investing strategy, and life. Same sleepy and trigger happy investors from Twitter.

Investing

Business

RSS

All content for Shooting the Bull With Drowsy and Bear is the property of Drowsy Investor and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Two old guys talking stocks, investing strategy, and life. Same sleepy and trigger happy investors from Twitter.

Investing

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43613845/43613845-1746564937672-37e006df6f1db.jpg

Episode 7: Andrea James on IMDX's Bright Future, Democratizing Molecular Diagnostics, and Investing Thoughts

Shooting the Bull With Drowsy and Bear

1 hour 24 seconds

4 weeks ago

Episode 7: Andrea James on IMDX's Bright Future, Democratizing Molecular Diagnostics, and Investing Thoughts

On this special October 2025 episode, Bear and Drowsy put on their lab coats and talk with Insight Molecular Diagnostics' (IMDX) Chief Financial Officer Andrea James on IMDX's strategy to build a moat in the race to democratize molecular diagnostics. Drowsy has one of his proudest investing moments. Bear, Drowsy, and AJ then discuss disrupting incumbents, what asymmetric investing opportunities and risks are emerging for IMDX, and a bit on broader investing strategies.

Stocks mentioned: IMDX, AXON, NVDA, and TSLA